Nathalie Hezard

Marseille, France

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 17 publications

A comprehensive multicenter study assessing the impact of abelacimab, asundexian, and milvexian on coagulation assays.

A comprehensive multicenter study assessing the impact of abelacimab, asundexian, and milvexian on coagulation assays.

Journal: Blood advances

Published: March 20, 2026

Circulating biomarkers of bronchoalveolar injury help predict the need for mechanical ventilation in patients with moderate to severe COVID-19 pneumonia: A prospective cohort study.

Circulating biomarkers of bronchoalveolar injury help predict the need for mechanical ventilation in patients with moderate to severe COVID-19 pneumonia: A prospective cohort study.

Journal: PloS one

Published: November 13, 2025

Expanded clinical, genetic, and biological spectrum of filaminopathies with hematological involvement.

Expanded clinical, genetic, and biological spectrum of filaminopathies with hematological involvement.

Journal: Haematologica

Published: June 17, 2025

Drug-Specific Calibration: A Solution to Reagent Variability in Extended Half-Life Factor IX Activity Measurements.

Drug-Specific Calibration: A Solution to Reagent Variability in Extended Half-Life Factor IX Activity Measurements.

Journal: Haemophilia : the official journal of the World Federation of Hemophilia

Published: March 19, 2025

Thrombomodulin (p.Cys537Stop) is released from cells by an unusual membrane insertion/leakage mechanism.

Thrombomodulin (p.Cys537Stop) is released from cells by an unusual membrane insertion/leakage mechanism.

Journal: Blood advances

Published: May 02, 2024

Surgery in rare bleeding disorders: the prospective MARACHI study.

Surgery in rare bleeding disorders: the prospective MARACHI study.

Journal: Research and practice in thrombosis and haemostasis

Published: February 02, 2023

Early changes in bleeding perception and quality of life in children and adolescents receiving emicizumab prophylaxis for severe haemophilia A without inhibitor.

Early changes in bleeding perception and quality of life in children and adolescents receiving emicizumab prophylaxis for severe haemophilia A without inhibitor.

Journal: Haemophilia : the official journal of the World Federation of Hemophilia

Published: October 03, 2022

Laboratory Techniques Used to Diagnose Constitutional Platelet Dysfunction.

Laboratory Techniques Used to Diagnose Constitutional Platelet Dysfunction.

Journal: Hamostaseologie

Published: September 15, 2020

Severe thrombophilia in a factor V-deficient patient homozygous for the Ala2086Asp mutation (FV Besançon).

Severe thrombophilia in a factor V-deficient patient homozygous for the Ala2086Asp mutation (FV Besançon).

Journal: Journal of thrombosis and haemostasis : JTH

Published: August 13, 2020

Receptor for Advanced Glycation End Products is Involved in Platelet Hyperactivation and Arterial Thrombosis during Chronic Kidney Disease.

Receptor for Advanced Glycation End Products is Involved in Platelet Hyperactivation and Arterial Thrombosis during Chronic Kidney Disease.

Journal: Thrombosis and haemostasis

Published: July 30, 2020

Emicizumab treatment: Impact on coagulation tests and biological monitoring of haemostasis according to clinical situations (BIMHO group proposals).

Emicizumab treatment: Impact on coagulation tests and biological monitoring of haemostasis according to clinical situations (BIMHO group proposals).

Journal: European journal of haematology

Published: June 10, 2020

Multicentre evaluation of CK Prest® for assaying plasma levels of factor IX fused with albumin (Idelvion® ).

Multicentre evaluation of CK Prest® for assaying plasma levels of factor IX fused with albumin (Idelvion® ).

Journal: Haemophilia : the official journal of the World Federation of Hemophilia

Published: February 22, 2019

Showing 1-12 of 17

Last Updated: 09/26/2026